Literature DB >> 20579891

Substituted 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]thiophene derivatives as potent tubulin polymerization inhibitors.

Romeo Romagnoli1, Pier Giovanni Baraldi, Maria Dora Carrion, Olga Cruz-Lopez, Manlio Tolomeo, Stefania Grimaudo, Antonietta Di Cristina, Maria Rosaria Pipitone, Jan Balzarini, Andrea Brancale, Ernest Hamel.   

Abstract

The central role of microtubules in cell division and mitosis makes them a particularly important target for anticancer agents. On our early publication, we found that a series of 2-(3',4',5'-trimethoxybenzoyl)-3-aminobenzo[b]thiophenes exhibited strong antiproliferative activity in the submicromolar range and significantly arrested cells in the G2-M phase of the cell cycle and induced apoptosis. In order to investigate the importance of the amino group at the 3-position of the benzo[b]thiophene skeleton, the corresponding 3-unsubstituted and methyl derivatives were prepared. A novel series of inhibitors of tubulin polymerization, based on the 2-(3,4,5-trimethoxybenzoyl)-benzo[b]thiophene molecular skeleton with a methoxy substituent at the C-4, C-5, C-6 or C-7 position on the benzene ring, was evaluated for antiproliferative activity against a panel of five cancer cell lines, for inhibition of tubulin polymerization and for cell cycle effects. Replacing the methyl group at the C-3 position resulted in increased activity compared with the corresponding 3-unsubstituted counterpart. The structure-activity relationship established that the best activities were obtained with the methoxy group placed at the C-4, C-6 or C-7 position. Most of these compounds exhibited good growth inhibition activity and arrest K562 cells in the G2-M phase via microtubule depolymerization. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20579891      PMCID: PMC2922916          DOI: 10.1016/j.bmc.2010.05.068

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  23 in total

Review 1.  Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin.

Authors:  Ernest Hamel
Journal:  Cell Biochem Biophys       Date:  2003       Impact factor: 2.194

Review 2.  Tubulin and microtubules as targets for anticancer drugs.

Authors:  John A Hadfield; Sylvie Ducki; Nicholas Hirst; Alan T McGown
Journal:  Prog Cell Cycle Res       Date:  2003

3.  Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain.

Authors:  Raimond B G Ravelli; Benoît Gigant; Patrick A Curmi; Isabelle Jourdain; Sylvie Lachkar; André Sobel; Marcel Knossow
Journal:  Nature       Date:  2004-03-11       Impact factor: 49.962

4.  Antimitotic natural products combretastatin A-4 and combretastatin A-2: studies on the mechanism of their inhibition of the binding of colchicine to tubulin.

Authors:  C M Lin; H H Ho; G R Pettit; E Hamel
Journal:  Biochemistry       Date:  1989-08-22       Impact factor: 3.162

5.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.

Authors:  C B Lozzio; B B Lozzio
Journal:  Blood       Date:  1975-03       Impact factor: 22.113

6.  Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A-4.

Authors:  G R Pettit; S B Singh; E Hamel; C M Lin; D S Alberts; D Garcia-Kendall
Journal:  Experientia       Date:  1989-02-15

7.  Design, synthesis and structure-activity relationship of 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]furan derivatives as a novel class of inhibitors of tubulin polymerization.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Maria Dora Carrion; Carlota Lopez Cara; Olga Cruz-Lopez; Manlio Tolomeo; Stefania Grimaudo; Antonietta Di Cristina; Maria Rosaria Pipitone; Jan Balzarini; Nicola Zonta; Andrea Brancale; Ernest Hamel
Journal:  Bioorg Med Chem       Date:  2009-08-20       Impact factor: 3.641

Review 8.  Microtubule dynamics and tubulin interacting proteins.

Authors:  C E Walczak
Journal:  Curr Opin Cell Biol       Date:  2000-02       Impact factor: 8.382

9.  Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cells.

Authors:  P Verdier-Pinard; J Y Lai; H D Yoo; J Yu; B Marquez; D G Nagle; M Nambu; J D White; J R Falck; W H Gerwick; B W Day; E Hamel
Journal:  Mol Pharmacol       Date:  1998-01       Impact factor: 4.436

10.  Separation of active tubulin and microtubule-associated proteins by ultracentrifugation and isolation of a component causing the formation of microtubule bundles.

Authors:  E Hamel; C M Lin
Journal:  Biochemistry       Date:  1984-08-28       Impact factor: 3.162

View more
  2 in total

1.  Tubulin inhibitors: pharmacophore modeling, virtual screening and molecular docking.

Authors:  Miao-Miao Niu; Jing-Yi Qin; Cai-Ping Tian; Xia-Fei Yan; Feng-Gong Dong; Zheng-Qi Cheng; Guissi Fida; Man Yang; Hai-Yan Chen; Yue-Qing Gu
Journal:  Acta Pharmacol Sin       Date:  2014-06-09       Impact factor: 6.150

2.  Discovery of 7-hydroxy-6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzo[b]furan (BNC105), a tubulin polymerization inhibitor with potent antiproliferative and tumor vascular disrupting properties.

Authors:  Bernard L Flynn; Gurmit S Gill; Damian W Grobelny; Jason H Chaplin; Dharam Paul; Annabell F Leske; Tina C Lavranos; David K Chalmers; Susan A Charman; Edmund Kostewicz; David M Shackleford; Julia Morizzi; Ernest Hamel; M Katherine Jung; Gabriel Kremmidiotis
Journal:  J Med Chem       Date:  2011-08-05       Impact factor: 7.446

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.